KanamycinThird Party Manufacturing in India

Kanamycin works by binding permanently to the 30S subunit of the bacterial ribosome, inducing a misreading of the genetic code. It halts essential protein synthesis to help the body clear aggressive bacterial overgrowth. Unlike common bacteriostatic agents, it provides a direct, rapid bactericidal effect against susceptible Gram-negative strains. It is highly effective and well-tolerated when utilized within established, short-course clinical treatment protocols.

Therapeutic Uses

• Severe Gram-Negative Bacillary Infections: Controls deep-seated systemic pathogens resistant to initial therapies.
• Second-Line Tuberculosis Treatment: Serves as a vital option within drug-resistant multi-therapy regimens.
• Acute Gonorrhea: Used in specific institutional scenarios to eradicate persistent bacterial strains.

Why Manufacturers Choose Kanamycin

Kanamycin remains an essential reserve antibiotic for addressing multi-drug resistant strains in domestic and international institutional markets. Opting for Kanamycin third party manufacturing in India helps distributors secure robust positions in public healthcare supply streams. Our partner facilities are WHO-GMP certified, utilizing advanced cleanroom automation and strict crystalline stability tracking to ensure high potency, excellent dissolution profiles, and long shelf life.